John L. Berk, M.D.

Faculty and Fellows

Associate Professor of Medicine
Director, Bronchoscopy Service, BMC
Associate Director, Pulmonary & Critical Care Medicine Fellowship
Associate Clinical Director, Amyloid Treatment and Research Program
Director, Amyloid Airway Clinic

BU Profile for Dr. Berk

Medical School: Case Western Reserve University School of Medicine (CWRU)
Internship: University Hospitals, CWRU
Residency: University Hospitals, CWRU
Fellowship: Pulmonary Fellowship, Boston University School of Medicine
Other Post-doctoral Fellowships/Training: Research Associate, Howard Hughes Medical Institute

Special Interests:


  • PI, Diflunisal Trial – FDA & NIH funded
  • Radiotherapy for tracheobronchial amyloidosis
  • Modulation of extracellular matrix gene expression by hypoxia


  • Lung manifestations of localized & systemic amyloidoses
  • Pulmonary fibrosis

John Berk attends on the Pulmonary Consult service and in the Medical Intensive Care Units. He directs the Bronchoscopy Service at Boston Medical Center, and is the Pulmonary Medicine and Critical Care expert of the multi-disciplinary Amyloid Treatment and Research Program, an internationally recognized center of excellence.

Dr. Berk is the Principal Investigator for an NIH & FDA funded international trial designed to establish whether diflunisal (Dolobid®) prevents neurologic disease progression in patients with familial amyloidotic polyneuropathy (FAP).

Selected Publications:

Please see BU Profile for complete publications list

Selected Reprints:

  1. Diaphragm paralysis in primary systemic amyloidosis
  2. Hypoxia suppresses elastin repair by rat lung fibroblasts
  3. Persistent Pleural Effusions in Primary Systemic Amyloidosis*
  4. Pulmonary and Tracheobronchial Amyloidosis